NCT07789340 Unipolar Versus Bipolar Radiofrequency Ablation in Knee Osteoarthritis Pain
| NCT ID | NCT07789340 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Bipolar Radiofrequency Ablation |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2026-08-29 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2026-08-29 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the efficacy of unipolar versus bipolar radiofrequency ablation (RFA) in knee osteoarthritis pain.
Eligibility Criteria
Inclusion Criteria: * Age \> 50 years. * Both genders. * Diagnosed with chronic knee osteoarthritis (KOA) according to the American College of Rheumatology (ACR) criteria and confirmed with plain radiography as the gold standard for the diagnosis of KOA. * One chronic KOA pain not responding to other treatments as physiotherapy, oral analgesics, and intraarticular injection with hyaluronic acids or steroids. * Kellgren-Lawrence grade (II-IV). Exclusion Criteria: * Chronic knee pain induced by infection, inflammation, tumors, and fractures. * Prior knee surgery. * Acute knee pain. * Connective tissue diseases. * Neurologic or psychiatric disorders. * Intra-articular knee corticosteroid or hyaluronic acids in the past 3 months. * Anticoagulant medication. * Local infection of the site of intervention. * Cognitive impairment.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07789340 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Bipolar Radiofrequency Ablation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07789340 currently recruiting?
Yes, NCT07789340 is actively recruiting participants. Contact the research team at mselsharkawy@med.tanta.edu.eg for enrollment information.
Where is the NCT07789340 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT07789340 clinical trial?
NCT07789340 is sponsored by Tanta University. The trial plans to enroll 64 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.